Compare IQV & LYV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | LYV |
|---|---|---|
| Founded | 1982 | 2005 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1B | 42.4B |
| IPO Year | 2013 | 2005 |
| Metric | IQV | LYV |
|---|---|---|
| Price | $270.87 | $170.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 21 |
| Target Price | ★ $227.13 | $182.38 |
| AVG Volume (30 Days) | 1.3M | ★ 1.7M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 1.61 | N/A |
| Revenue | $9,739,000,000.00 | ★ $25,201,406,000.00 |
| Revenue This Year | $6.77 | $10.24 |
| Revenue Next Year | $5.89 | $9.37 |
| P/E Ratio | $170.82 | ★ N/A |
| Revenue Growth | ★ 41.60 | 8.83 |
| 52 Week Low | $154.50 | $125.34 |
| 52 Week High | $277.40 | $189.25 |
| Indicator | IQV | LYV |
|---|---|---|
| Relative Strength Index (RSI) | 62.05 | 43.88 |
| Support Level | $159.91 | $171.00 |
| Resistance Level | $271.80 | $174.61 |
| Average True Range (ATR) | 6.37 | 3.79 |
| MACD | -0.65 | 0.19 |
| Stochastic Oscillator | 73.64 | 57.43 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 51 countries, Live Nation promotes concerts globally. It owned, operated, or had exclusive booking rights to more than 400 venues worldwide at the end of 2025, which the firm says makes it the second-largest operator of music venues globally. In 2025, Live Nation promoted nearly 55,000 events, drawing roughly 160 million fans. Ticketmaster is a dominant global ticketing service, selling nearly 650 million tickets in 2025.